GLP-1 medications reduce total caloric intake by suppressing appetite. This mechanism does not discriminate between food types: patients eat less protein along with less fat and less carbohydrate. In standard dietary patterns, protein typically accounts for fifteen to twenty percent of total calories. If total caloric intake falls by thirty to fifty percent on GLP-1 treatment, protein intake falls proportionally unless deliberate steps are taken to change the composition of what is eaten, not just how much.
The Baseline Requirement Has Already Been Underestimated
The current recommended daily allowance for protein in the UK is 0.75 grams per kilogram of body weight. This figure was established to prevent deficiency in the general population, not to optimise muscle maintenance in adults undergoing weight loss. The research literature on muscle preservation during caloric restriction consistently identifies a threshold of 1.6 grams per kilogram of body weight as the minimum for maintaining lean mass. For a 75 kilogram adult, this is 120 grams of protein per day, sixty percent higher than the standard recommendation. Many adults on GLP-1 medications are consuming significantly less than the standard recommendation, let alone the therapeutic one.
Anabolic Resistance Makes the Problem Worse After 40
Adults over 35 experience anabolic resistance: the reduced sensitivity of aging muscle to the protein synthesis signal provided by dietary amino acids. A younger adult can adequately stimulate muscle protein synthesis with twenty grams of protein per meal. An adult over 60 may require thirty-five to forty grams per meal to achieve the same response. When GLP-1-induced appetite suppression reduces meal sizes and frequency simultaneously, older adults face a compounded challenge: lower total protein intake combined with lower per-meal efficiency, at precisely the life stage when preserving lean mass is most critical.
Practical Strategies for Hitting Protein Targets on Reduced Appetite
The central practical challenge is achieving high protein intake when total food volume tolerance is reduced. Protein-dense foods that provide the most protein per unit of volume and satiation include Greek yoghurt at approximately 17 grams per 170-gram serving, cottage cheese at approximately 14 grams per 100 grams, eggs at 6 grams each, chicken breast at 31 grams per 100 grams cooked, canned tuna at 25 grams per 100 grams, and whey protein powder at 20 to 25 grams per serving in a small liquid volume. Distributing protein intake across three meals, each containing 35 to 45 grams, is more effective than attempting to consume it in one or two larger meals.
Liquid protein sources, including milk, high-protein shakes, and Greek yoghurt smoothies, are particularly useful in the early weeks of GLP-1 treatment when nausea limits solid food tolerance. A protein shake containing 25 to 30 grams of whey protein in 250 millilitres of milk provides 35 to 40 grams of protein in a format that is typically well tolerated even during significant nausea.
- Target 1.6 to 2.2 grams of protein per kilogram of body weight daily throughout GLP-1 treatment
- For a 75kg adult this means 120 to 165 grams of protein per day
- Adults over 35 need 35 to 45 grams per meal to stimulate muscle protein synthesis adequately
- Prioritise protein first at each meal before appetite is exhausted
- High-density options: Greek yoghurt, cottage cheese, eggs, chicken breast, tuna, whey protein
- Liquid protein sources are useful when solid food nausea limits intake
- Track protein intake with a food diary for the first 4 to 6 weeks to establish accurate baseline habits